370593-25-2

Upstream product

• 370593-32-1 (4aR,8R,8aS)-8-(tert-Butyl-diphenyl-silanyloxy)-7-iodo-2,2-diisopropyl-4a-methyl-4,4a,8,8a-tetrahydro-1,3,5-trioxa-2-sila-naphthalene 
• 370593-31-0 4-(tert-butyl-diphenyl-silanyloxy)-2-hydroxymethyl-5-iodo-2-methyl-3,4-dihydro-2H-pyran-3-ol 
• 370593-29-6 (2S,3R)-3-Acetoxy-5-iodo-2-methyl-4-oxo-3,4-dihydro-2H-pyran-2-carboxylic acid ethyl ester 
• 370593-30-9 (2S,3S,4R)-3,4-Dihydroxy-5-iodo-2-methyl-3,4-dihydro-2H-pyran-2-carboxylic acid ethyl ester 
• 370593-28-5 (2S,3R)-3-Acetoxy-2-methyl-4-oxo-3,4-dihydro-2H-pyran-2-carboxylic acid ethyl ester 
• 370593-27-4 (2S,3S)-3-Acetoxy-2-methyl-4-oxo-3,4-dihydro-2H-pyran-2-carboxylic acid ethyl ester 
• 200421-45-0 (S)-2-methyl-4-oxo-3,4-dihydro-2H-pyran-2-carboxylic acid ethyl ester 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 370593-36-5 (E)-3-[(4aR,8S,8aS)-8-(tert-Butyl-diphenyl-silanyloxy)-2,2-diisopropyl-4a-methyl-4,4a,8,8a-tetrahydro-1,3,5-trioxa-2-sila-naphthalen-7-yl]-prop-2-en-1-ol 

Relevant academic research and scientific papers

Enantioselective synthesis of the oxadecalin core of phomactin A via a highly stereoselective Diels-Alder reaction

matrix presented Phomactin A (1) is a selective antagonist of platelet activating factor (PAF). Herein, we report our progress toward the construction of the oxadecalin core of 1. This route is based on the Diels-Alder cycloaddition of an appropriately fu